SPA Stock Overview
Spanjaard Limited, through its subsidiaries, manufactures and distributes specialized lubricants and allied chemical products worldwide.
Price History & Performance
|Historical stock prices|
|Current Share Price||R3.82|
|52 Week High||R4.15|
|52 Week Low||R2.59|
|1 Month Change||-1.80%|
|3 Month Change||5.82%|
|1 Year Change||-8.83%|
|3 Year Change||52.80%|
|5 Year Change||46.92%|
|Change since IPO||409.33%|
Recent News & Updates
|SPA||ZA Chemicals||ZA Market|
Return vs Industry: SPA underperformed the ZA Chemicals industry which returned 53% over the past year.
Return vs Market: SPA underperformed the ZA Market which returned 14.4% over the past year.
|SPA Average Weekly Movement||3.4%|
|Chemicals Industry Average Movement||4.4%|
|Market Average Movement||5.7%|
|10% most volatile stocks in ZA Market||11.4%|
|10% least volatile stocks in ZA Market||3.3%|
Stable Share Price: SPA is less volatile than 75% of ZA stocks over the past 3 months, typically moving +/- 3% a week.
Volatility Over Time: SPA's weekly volatility has decreased from 13% to 3% over the past year.
About the Company
Spanjaard Limited, through its subsidiaries, manufactures and distributes specialized lubricants and allied chemical products worldwide. It operates through Automotive, Industrial, Exports, and Consumer Goods segments. The company produces a range of food aerosol products; trades in anti-friction powders; and sells fuel additives, greases, and car care products.
Spanjaard Fundamentals Summary
|SPA fundamental statistics|
Is SPA overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|SPA income statement (TTM)|
|Cost of Revenue||R89.47m|
Last Reported Earnings
Aug 31, 2021
Next Earnings Date
|Earnings per share (EPS)||0.57|
|Net Profit Margin||3.23%|
How did SPA perform over the long term?See historical performance and comparison
Is Spanjaard undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: SPA (ZAR3.82) is trading below our estimate of fair value (ZAR9.78)
Significantly Below Fair Value: SPA is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: SPA is good value based on its PE Ratio (6.7x) compared to the ZA Chemicals industry average (11.2x).
PE vs Market: SPA is good value based on its PE Ratio (6.7x) compared to the ZA market (10.7x).
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate SPA's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: SPA is good value based on its PB Ratio (0.6x) compared to the ZA Chemicals industry average (1.2x).
How is Spanjaard forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Materials industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Spanjaard has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
How has Spanjaard performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: SPA has high quality earnings.
Growing Profit Margin: SPA's current net profit margins (3.2%) are higher than last year (2.7%).
Past Earnings Growth Analysis
Earnings Trend: SPA's earnings have grown significantly by 27.4% per year over the past 5 years.
Accelerating Growth: SPA's earnings growth over the past year (40.8%) exceeds its 5-year average (27.4% per year).
Earnings vs Industry: SPA earnings growth over the past year (40.8%) exceeded the Chemicals industry 37.2%.
Return on Equity
High ROE: SPA's Return on Equity (8.8%) is considered low.
How is Spanjaard's financial position?
Financial Position Analysis
Short Term Liabilities: SPA's short term assets (ZAR62.5M) exceed its short term liabilities (ZAR28.8M).
Long Term Liabilities: SPA's short term assets (ZAR62.5M) exceed its long term liabilities (ZAR17.5M).
Debt to Equity History and Analysis
Debt Level: SPA has more cash than its total debt.
Reducing Debt: SPA's debt to equity ratio has reduced from 16.8% to 16.1% over the past 5 years.
Debt Coverage: SPA's debt is well covered by operating cash flow (106.4%).
Interest Coverage: SPA's interest payments on its debt are well covered by EBIT (13.4x coverage).
What is Spanjaard current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate SPA's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate SPA's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if SPA's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if SPA's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: SPA is not paying a notable dividend for the ZA market.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of SPA's dividend in 3 years as they are not forecast to pay a notable one for the ZA market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Tracy Spanjaard (38 yo)
Ms. Tracy Nelly Spanjaard has been Executive Director and Chief Executive Officer at Spanjaard Ltd. since September 01, 2020 and was Director of Marketing at Spanjaard Limited since October 12, 2017 until...
CEO Compensation Analysis
Compensation vs Market: Tracy's total compensation ($USD89.26K) is below average for companies of similar size in the ZA market ($USD265.29K).
Compensation vs Earnings: Tracy's compensation has increased by more than 20% in the past year.
Experienced Management: SPA's management team is not considered experienced ( 1.8 years average tenure), which suggests a new team.
Experienced Board: SPA's board of directors are not considered experienced ( 2.4 years average tenure), which suggests a new board.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Spanjaard Limited's employee growth, exchange listings and data sources
- Name: Spanjaard Limited
- Ticker: SPA
- Exchange: JSE
- Founded: 1960
- Industry: Specialty Chemicals
- Sector: Materials
- Implied Market Cap: R31.106m
- Shares outstanding: 8.14m
- Website: https://www.spanjaard.biz
Number of Employees
- Spanjaard Limited
- 748 - 750 Fifth Street
- South Africa
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/01/12 17:00|
|End of Day Share Price||2022/01/04 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.